Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relationships between time in target range and A1C (25; 26) and number of severe and non-severe hypoglycemic events (27-31) have also been observed.”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [31]
In the citing paper
“Nevertheless, our analysis in people without diabetes are in line with the International Hypoglycaemia Study Group (IHSG) classification for hypoglycaemia, particularly regarding level 1 hypoglycaemia [78].”
From Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review (2022) · cites this paper as [78]
In the citing paper
“The severity of hypoglycemia is not strictly defined by glucose levels, but is characterized by the severity of the associated symptoms of hypoglycemia and risks, as defined by the International Hypoglycemia Study Group [14] (Tables 2 and 3).”
From Hypoglycemia in Adults (2023) · cites this paper as [14]
Citations
Cites
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009 · cited 1×
“NICE-SUGAR trial (23) and, possibly, in”
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403
Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Research works printed but not linked: 1
- Cryer, 2001, The prevention and correction of hypoglycemia, 1057
Cited by
Items 201–300 of 615
McAuley, S. A., Vogrin, S., Lee, M. H., Paldus, B., Trawley, S. L., de Bock, M. I., Abraham, M. B., Bach, L. A., Burt, M. G., Cohen, N. D., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0589 · Cited by 21
Beck, R. W., & Bergenstal, R. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0090 · Cited by 23
Predicting and Reducing Driving Mishaps Among Drivers With Type 1 Diabetes
Cox, D. J., Gonder-Frederick, L. A., Singh, H., Ingersoll, K. S., Banton, T. A., Grabman, J. H., Schmidt, K., & Clarke, W. L. (2017) · Diabetes Care · doi:10.2337/dc16-0995 · Cited by 21
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., Holmes, V., Green Pastors, J., Wolf, A., Fang, K., & McCall, A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001795 · Cited by 20
Time in Range as a Research Outcome Measure
Timmons, J. G., Boyle, J. G., & Petrie, J. R. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0097 · Cited by 23
Bochanen, N., Decochez, K., Heleu, E., Cuypers, J., Vercammen, C., Coremans, P., Vanhaverbeke, G., Shadid, S., Keymeulen, B., Bolsens, N., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14672 · Cited by 20
Flatt, A. J., Chen, E., Peleckis, A. J., DALTON-BAKES, C. V., Nguyen, H.-L., Collins, H. W., Millar, J. S., Gallop, R., & Rickels, M. R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0103 · Cited by 23
Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial
Sinclair, A. J., Heller, S. R., Pratley, R. E., Duan, R., Heine, R. J., Festa, A., & Kiljanski, J. I. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14013 · Cited by 19
Luczkowska, K., Stekelenburg, C., Béna, F., Ranza, E., Gastaldi, G., Schwitzgebel, V., & Maechler, P. (2020) · Human Genomics · doi:10.1186/s40246-020-00262-8 · Cited by 19
Heller, S. R., Pratley, R. E., Sinclair, A., Festa, A., Kiljański, J., Brusko, C. S., Duan, R., & Heine, R. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13051 · Cited by 18
Chien, A., THANASEKARAN, S., Gaetano, A., IM, G. H., Wherry, K., MacLeod, J., & Vigersky, R. A. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.22283 · Cited by 20
Bergenstal, R. M., Ásbjörnsdóttir, B., Watt, S. K., Lingvay, I., Mader, J. K., Nishida, T., & Rosenstock, J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00220-1 · Cited by 18
Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes
Henao, D. C., Múñoz, Ó., Gómez, A. M., Rondón, M., Colon, C. A., Chica, L. G., Rubio, C., Vargas, F. M. L., Calvachi, M. A., & Perea, A. M. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.03.003 · Cited by 21
Singh‐Franco, D., Moreau, C. S., Levin, A., Rosa, D. D. L., & Johnson, M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.06.024 · Cited by 18
Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes
Jones, T. W., & On behalf of the ISPAD Hypoglycemia Guidelines Writing Group (2017) · Pediatric Diabetes · doi:10.1111/pedi.12600 · Cited by 19
Garden, G. L., Hine, J. L., Mitchell, S. J., Hutchison, E. J., Gaffney, T. P., Hofmann, V., Frier, B. M., Shaw, K. M., Heller, S. R., Koehler, G., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0277 · Cited by 17
Willis, H. J., Asche, S. E., McKenzie, A. L., Adams, R. N., Roberts, C. G. P., Volk, B. M., Krizka, S., Athinarayanan, S. J., Zoller, A. R., & Bergenstal, R. M. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0406 · Cited by 17
“19 Further research is needed to understand the importance of time with glucose 70 mg/dL, but ‡ 54 mg/dL, in people with low-risk for hypoglycemia — especially given the growing interest in CGM use by people with prediabetes and people with T2D who are not using insulin.”
Nielsen, C. K., Øhrstrøm, C. C., Houji, I. J. K., Helsted, M. M., Krogh, L. S. L., Johansen, N. J., Hartmann, B., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2023) · Diabetes Care · doi:10.2337/dc23-1193 · Cited by 19
Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump
Thrasher, J., Surks, H., Nowotny, I., Pierre, S., Rotthaeuser, B., Wernicke-Panten, K., & Garg, S. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817753644 · Cited by 17
Amor, A. J., Ortega, E., Giménez, M., Cofán, M., Blanco, J., Pané, A., Boswell, L., Vinagre, I., Esmatjes, E., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.02.004 · Cited by 19
Coates, E. J., Amiel, S. A., Baird, W. O., Benaissa, M., Brennan, A., Campbell, M. J., Chadwick, P., Chater, T., Choudhary, P., Cooke, D. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040438 · Cited by 17
“Episodes of severe hypoglycaemia (as defined by the American Diabetes Association [9]), and”
BackgroundMethodInfluentialFabricius, T. W., Verhulst, C. E. M., Kristensen, P. L., Tack, C. J., McCrimmon, R. J., Heller, S. R., Evans, M. L., Amiel, S. A., Pieber, T. R., de Galan, B. E., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05361-8 · Cited by 17
the RESTORE-1 Study Group, Laviola, L., Porcellati, F., Bruttomesso, D., Larosa, M., Rossi, M. C., & Nicolucci, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00982-z · Cited by 16
Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia
Schönenberger, K. A., Cossu, L., Prendin, F., Cappon, G., Wu, J., Fuchs, K. L., Mayer, S., Herzig, D., Facchinetti, A., & Bally, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.855223 · Cited by 16
Jacob, P., Potts, L. C., Maclean, R., de Zoysa, N., Rogers, H., Gonder-Frederick, L. A., Smith, E. L., Kariyawasam, D., Brooks, A. M., Heller, S. R., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05679-5 · Cited by 19
Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies
Demirbilek, H., Vurallı, D., Haris, B., & Hussain, K. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s313837 · Cited by 23
Visolyi, G. Á., Domján, B. A., Svébis, M. M., Péterfi, A., Lovasz, B. D., Mészáros, S., Horváth, V. J., & Tabák, Á. G. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.03.002 · Cited by 18
Hypoglycaemia in cystic fibrosis: An analysis of a single centre adult cystic fibrosis clinic
Armaghanian, N., Markovic, T., Brand-Miller, J. C., Bye, P. T. P., Moriarty, C. P., & Steinbeck, K. S. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.11.015 · Cited by 16
“[5] as well as the recent guidelines from the International Hypoglycaemia Study Group [13] which defines glucose b3 mmol/L as clinically significant.”
MethodCrutzen, S., Nagaraj, S. B., Taxis, K., & Denig, P. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3426 · Cited by 17
Continuous glucose monitoring to assess glucose variability in type 3c diabetes
Lee, V. T. Y., Poynten, A. M., & Depczynski, B. (2022) · Diabetic Medicine · doi:10.1111/dme.14882 · Cited by 17
Buysse, H. E. C., Coremans, P., Pouwer, F., & Ruige, J. B. (2019) · Health Informatics Journal · doi:10.1177/1460458219844369 · Cited by 21
Hatle, H., Bjørgaas, M. R., Skrivarhaug, T., Åsvold, B. O., Graveling, A. J., Frier, B. M., & Rø, T. B. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12951 · Cited by 15
Diabetes Management Experience and the State of Hypoglycemia: National Online Survey Study
Zahed, K., Sasangohar, F., Mehta, R. K., Erraguntla, M., & Qaraqe, K. A. (2020) · JMIR Diabetes · doi:10.2196/17890 · Cited by 16
Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia
Craig, C. M., & McLaughlin, T. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.06.013 · Cited by 17
Ferreira, A., Schönenberger, K. A., Potoczna, N., Vogt, A. P., Gerber, P. A., Zehetner, J., Giachino, D., Nett, P. C., Gawinecka, J., Cossu, L., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0036 · Cited by 16
Outcome-Based Critical Result Thresholds in the Adult Patient Population
Tan, E. H., Yang, Z., Li, Y., Metz, M. P., & Loh, T. P. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz026 · Cited by 15
Farrell, C. M., McNeilly, A. D., Hapca, S. M., & McCrimmon, R. J. (2020) · Diabetes Care · doi:10.2337/dc20-0882 · Cited by 15
Prasad, A., Roy, A. C., Priya, K., Meena, R., & Ghosh, I. (2023) · 3 Biotech · doi:10.1007/s13205-023-03759-w · Cited by 17
Umpierrez, G. E., Castro-Revoredo, I., Moazzami, B., Nayberg, I., Zabala, Z. E., Galindo, R. J., Vellanki, P., Peng, L., & Klonoff, D. C. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.11.018 · Cited by 16
Trajectories of Fetal Adipose Tissue Thickness in Pregnancies After Gastric Bypass Surgery
Yerlikaya‐Schatten, G., Feichtinger, M., Linder, T., Huhn, E. A., Chalubinski, K. M., Husslein, P. W., Eppel, W., Schatten, C., & Göbl, C. S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04115-9 · Cited by 17
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis
Weiss, L. M., Reix, P., Mosnier-Pudar, H., Ronsin, O., Beltrand, J., Reynaud, Q., Mély, L., Burgel, P., Stremler, N., Rakotoarisoa, L., et al. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101444 · Cited by 15
Lo, S., Yang, Y., Kornelius, E., Huang, J., Lai, Y., Huang, C., & Chiou, J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13746 · Cited by 14
“Although we did not measure patients' plasma glucose, we used the diagnosis code for hypoglycaemia from emergency and inpatient claims, which corresponds with the ADA definition of severe hypoglycaemia.(28) Second, we did not identify patients with non-severe hypoglycaemia in our study.”
MethodEfficacy and Safety of Ideglira in Older Patients with Type 2 Diabetes
Lingvay, I., Handelsman, Y., Linjawi, S., Vilsbøll, T., Halladin, N., Ranc, K., & Liebl, A. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0284 · Cited by 18
Hoffman, E. G., D’Souza, N. C., Liggins, R. T., & Riddell, M. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1295639 · Cited by 13
Mellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06225-1 · Cited by 16
Baranyi, R., Willinger, R., Lederer, N., Walcher, F., & Grechenig, T. (2018) · SeGAH ... IEEE ... International Conference on Serious Games and Applications for Health/IEEE International Conference on Serious Games and Applications for Health · doi:10.1109/segah.2018.8401352 · Cited by 13
“overdosing or low food intake [3] and is reflected in impaired cognitive functioning [9].”
BackgroundImpact of structured insulin order sets on inpatient hypoglycemia and glycemic control
Kravchenko, M. I., Tate, J. M., Clerc, P. G., Forbes, W. L., Gettle, M. C., Wardian, J. L., & Colburn, J. A. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0341 · Cited by 13
Yun, J., Han, K., Park, Y., Han, E., Lee, Y., & Ko, S. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13818 · Cited by 16
Madar, H., Wu, Z., Bandini, A., Perkins, B. A., Messier, V., Pomey, M., Brazeau, A., & RABASA-LHORET, R. P. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01987-9 · Cited by 16
Diabetesmanagement im Krankenhaus (Update 2023)
Mader, J. K., Brix, J. M., Aberer, F., Vonbank, A., Resl, M., Hochfellner, D. A., Ress, C., Pieber, T. R., Stechemesser, L., & Sourij, H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02177-5 · Cited by 15
Kuchay, M. S., Khatana, P., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Singh, A., Jain, R., Kohli, C., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02138-4 · Cited by 16
“We also determined the number of patients with hypoglycemia as defined by the American Diabetes Association, defined as glucose 70 mg/dL, clinically significant hypoglycemia ( 54 mg/dL), or severe hypoglycemia ( 40 mg/dL) [11].”
BackgroundLimitations of Reporting Time Below Range as a Percentage
Shah, V. N. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0247 · Cited by 13
“…threshold to define hypoglycemia and, therefore, the consensus recommended that a glucose value of 70 mg/dL or less should be considered as an alert value to prevent clinically harmful low glucose value of 54 mg/dL. 7 However, recommending a target for an alert level (TBR 70 mg/dL of 4”
Sell, J. J., Haas, N. L., Korley, F. K., Cranford, J. A., & Bassin, B. S. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.60361 · Cited by 13
Hypoglycemia, Malnutrition and Body Composition
Khanimov, I., Shimonov, M., Wainstein, J., & Leibovitz, E. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_526 · Cited by 14
He, A., Zuo, D., Liang, X., Guo, Y., Suxin, L., & Xia, Y. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104075 · Cited by 14
Glucagon for hypoglycaemia treatment in type 1 diabetes
Ranjan, A. G., Schmidt, S., & Nørgaard, K. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3409 · Cited by 17
Lee, C. J., Clark, J. M., Egan, J. M., Carlson, O. D., Schweitzer, M., Langan, S. J., & Brown, T. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac455 · Cited by 14
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
“The severity of hypoglycemia is not strictly de fi ned by glucose levels, but is characterized by the severity of the associated symptoms of hypoglycemia and risks, as de fi ned by the International Hypoglycemia Study Group [14] (Tables 2 and 3).”
BackgroundMethodLucci, C., Marongiu, A., Genovese, S., Mazza, M., Cosentino, N., & Marenzi, G. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02862-x · Cited by 12
Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus
Frier, B. M., Ratzki‐Leewing, A. A., & Harris, S. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13732 · Cited by 12
Yang, T., Ziemba, R. E., Shehab, N., Geller, A. I., Talreja, K., Campbell, K. N., & Budnitz, D. S. (2022) · Medical Care · doi:10.1097/mlr.0000000000001682 · Cited by 12
Khan, S. A., Shields, S. A., Abusamaan, M. S., & Mathioudakis, N. N. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108305 · Cited by 14
Hypoglycaemia Among Diabetes Patients: A Preventive Approach
Mohajan, D., & Mohajan, H. K. (2023) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2023.09.05 · Cited by 12
Monnier, L., Colette, C., & Owens, D. R. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.06.004 · Cited by 13
Hong, J. G. S., Tan, P. C., Kamarudin, M., & Omar, S. Z. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03628-5 · Cited by 12
Spontaneous and iatrogenic hypoglycemia in cystic fibrosis
Hicks, R. A., Marks, B. E., Oxman, R., & Moheet, A. A. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100267 · Cited by 15
Oe, Y., Nomoto, H., Nakamura, A., Kuwabara, S., Takahashi, Y., Yasui, A., Izumihara, R., Miya, A., Kameda, H., Cho, K. Y., et al. (2022) · Journal of Diabetes Research · doi:10.1155/2022/5603864 · Cited by 12
Hypoglycemia Prevention by Algorithm Design During Intravenous Insulin Infusion
Braithwaite, S. S., Clark, L., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0994-4 · Cited by 12
Pedersen, C., Bouman, S. D., Porsgaard, T., ROSENKILDE, M. M., & Roed, N. K. (2018) · Physiological Reports · doi:10.14814/phy2.13657 · Cited by 12
Vihonen, H., Kuisma, M., & Nurmi, J. (2018) · Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · doi:10.1186/s13049-018-0480-7 · Cited by 11
Zucchini, S., Tumini, S., Scaramuzza, A. E., Bonfanti, R., Delvecchio, M., Franceschi, R., Iafusco, D., Lenzi, L., Mozzillo, E., Passanisi, S., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1387537 · Cited by 12
Berry, S. A., Liarakos, A. L., Koutroukas, V., Choudhary, P., Wilmot, E. G., & Iqbal, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16284 · Cited by 12
BRUGINSKI, D., Précoma, D. B., Sabbag, A. E., & Olandowski, M. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815999190619141622 · Cited by 13
Barlas, T., Yalçın, M. M., Coşkun, M., Demirel, D., Altınova, A. E., Törüner, F. B., Karakoç, M. A., Yetkin, İ., & Aktürk, M. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.008 · Cited by 12
Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms
Cederblad, L., Eklund, G., Vedal, A., Hill, H., Caballero-Corbalán, J., Hellman, J., Abrahamsson, N., Johnsson, I. W., Carlsson, P., & Espes, D. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01403-7 · Cited by 11
An overview of insulin therapy for the non‐specialist
Home, P. D. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16280 · Cited by 13
“52,53 But it is a much bigger problem in T1DM (nearly universal in any year) than in T2DM.”
Fulcher, G., Mehta, R., Fita, E. G., Ekelund, M., & Bain, S. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0531-0 · Cited by 12
Sawani, S., Siddiqui, A. R., Azam, S. I., Humayun, K. N., Ahmed, A., Habib, A., Naz, S., Tufail, M., & Iqbal, R. (2020) · Trials · doi:10.1186/s13063-020-4205-7 · Cited by 11
Lee, C., Lui, D. T. W., Cheung, C. Y. Y., Woo, Y. C., Fong, C. H.-Y., Yuen, M. M. A., Shea, Y. F., Siu, D. C. W., Chan, K., Chow, W., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3401 · Cited by 13
Mao, Y., Zhao, X., Zhou, L., Lü, B., Jin, C., Fu, D., Yao, L., & Li, J. (2021) · Gland Surgery · doi:10.21037/gs-21-495 · Cited by 13
Sliding scale insulin use in a national cohort study of nursing home residents with type 2 diabetes
Lam, K., Gan, S., Nguyen, B., Jing, B., & Lee, S. J. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17771 · Cited by 11
Heller, S. R., & Novodvorský, P. (2018) · Medicine · doi:10.1016/j.mpmed.2018.10.005 · Cited by 11
Sepúlveda, E., Jacob, P., Poínhos, R., Carvalho, D. M., Vicente, S., Smith, E. L., Shaw, J., Speight, J., Choudhary, P., de Zoysa, N., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05847-7 · Cited by 12
Khunti, K., Berković, M. C., Ludvik, B. H., Moberg, E., Lekdorf, J. B., Gydesen, H., & Pedersen‐Bjergaard, U. (2018) · Diabetic Medicine · doi:10.1111/dme.13662 · Cited by 12
Bosnyák, Z., Zhou, F. L., Jiménez, J., & Berria, R. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0567-9 · Cited by 11
Mongraw‐Chaffin, M., Beavers, D. P., & McClain, D. A. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100202 · Cited by 13
Garg, S. K., Wernicke‐Panten, K., Wardęcki, M., Kramer, D., Delalande, F., Franek, E., Sadeharju, K., Monchamp, T., Miossec, P., Mukherjee, B., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0008 · Cited by 11
Kawaguchi, Y., Sawa, J., Hamai, C., Nishimura, Y., & Kumeda, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13038 · Cited by 10
Bano, A., Künzler, J., Wehrli, F., Kastrati, L., Rivero, T. M., Llane, A., Gris, A. V., Fraser, A. G., Stettler, C., Hovorka, R., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15849 · Cited by 10
Ishii, H., Kamiya, H., Takahashi, Y., Morimoto, Y., & Yabe, D. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01645-z · Cited by 11
Diabetes and Driving: A Statement of the American Diabetes Association
Cox, D. J., Frier, B. M., Bruggeman, B., Durrani, T. S., ElSayed, N. A., Bannuru, R. R., Fischer, A., Griffin, J., Kohrman, D. B., May, A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0068 · Cited by 14
Analytical Accuracy of a Continuous Glucose Monitor in Adult Diabetic Ketoacidosis
Haas, N. L., Ang, L. P., Esfandiari, N. H., Khan, A. M., Cranford, J. A., Cohen, A., Sell, J. J., Abdel-Hamid, M., Romanchik, K. E., & Korley, F. K. (2024) · CHEST Critical Care · doi:10.1016/j.chstcc.2024.100109 · Cited by 11
Lu, T., Fan, J., You, S., Adiraju, A., Guo, Y., Talbi, M., Jaradat, H., & Kanoun, O. (2025) · Emergent Materials · doi:10.1007/s42247-025-01279-2 · Cited by 10
Hypoglycemia Reduction Strategies in the ICU
Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 13
Low normal fasting glucose and risk of accidental death in Korean adults: A prospective cohort study
Yi, S., Won, Y. J., & Yi, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.005 · Cited by 10
Warren, M., Bergenstal, R. M., Hager, M., Bashan, E., & Hodish, I. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0041 · Cited by 11
Rosenstock, J., BAJAJ, H. S., Lingvay, I., & Heller, S. R. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003930 · Cited by 12
“Itemized outcomes, including incidence rates and number of participants reporting hypoglycemia, for each individual trial are shown in online supplemental tables 5 and 6.”
Furler, J., O'Neal, D. N., Speight, J., Blackberry, I., Manski-Nankervis, J.-A. E., Thuraisingam, S., Rue, K. D. L., Ginnivan, L., Browne, J. L., Holmes‐Truscott, E., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021435 · Cited by 12
Kao, S. L., Chen, Y., Ning, Y., Tan, M. L. S., Salloway, M. K., Khoo, E. Y. H., Tai, E. S., & Tan, C. S. (2020) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00107-2 · Cited by 10
Stuckey, H. L., Desai, U. S., King, S. B., Popadic, L., Levinson, W., Kirson, N. Y., Hankosky, E. R., & Mitchell, B. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14745 · Cited by 10
Metadata
- Authors
- International Hypoglycaemia Study Group
- Corresponding author
- International Hypoglycaemia Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-10
- Volume
- 40
- Issue
- 1
- Pages
- 155-157
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4247704066
- Cited by
- 608
- References
- 24
- Citations by year
- 2026: 34 · 2025: 37 · 2024: 50 · 2023: 61 · 2022: 76 · 2021: 60 · 2020: 93 · 2019: 86 · 2018: 73 · 2017: 36 · 2016: 2
- FWCI
- 55.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0515-10079)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia, glucose concentration, hypoglycemic events, clinical trial reporting, hypoglycemia definition, European Association for the Study of Diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.